Certara Executive and Leadership Team

May, 2026

Leadership Overview

Certara has 10 executives leading key functions including strategy, technology, finance, marketing, human resources, data sciences, drug development, and interim development.

Driven by innovation, Certara provides essential services and software across the entire drug development lifecycle, from initial discovery through to market access, impacting global health outcomes.

Leadership Roles at Certara

  • Chief Executive Officer - Jon Resnick
  • Chief Financial Officer - Kelly Brooks
  • President, Certara Data Sciences - Martin Snyder
  • President & Founder - Paul Gallagher
  • President, Certara Drug Development Solutions - Adrian McKemey
  • Chief Technology Officer - Chris Bouton
  • Chief Marketing Officer - Sheila Rocchio
  • Chief Human Resources Officer - Rona Anhalt
  • Interim Chief Development Officer - John Gallagher
  • Member of the Board - Cynthia Collins
  • Jon Resnick - Chief Executive Officer

    Jon Resnick, the Chief Executive Officer at Certara, directs the company's overarching strategy and operational execution. Resnick guides Certara's mission to accelerate the development of life-changing medicines by providing critical services and software solutions. Overseeing global operations, the Chief Executive Officer ensures alignment with corporate objectives and market demands. This leadership role involves driving innovation and fostering a culture of scientific excellence across all divisions. By optimizing resource allocation and strategic partnerships, Jon Resnick directly impacts the company's growth and its ability to serve clients worldwide. Ultimately, Resnick secures Certara's position as a leader in the drug development ecosystem.
    Jon Resnick

    Kelly Brooks - Chief Financial Officer

    Kelly Brooks, the Chief Financial Officer at Certara, manages the company's financial strategy and operations. Brooks oversees all fiscal activities, including budgeting, forecasting, and financial reporting, ensuring fiscal health and strategic resource allocation. Directing financial planning, the Chief Financial Officer supports Certara's growth objectives and operational efficiency across its global locations. This critical role involves managing investor relations and capital management to fund expansion and innovation. By providing financial insights and controls, Kelly Brooks directly impacts Certara's profitability and long-term sustainability. Ultimately, Brooks safeguards the company's financial integrity and drives value for stakeholders.

    Martin Snyder - President, Certara Data Sciences

    Martin Snyder, the President of Certara Data Sciences at Certara, directs the company's advanced data analytics and modeling capabilities. Snyder leads the teams responsible for generating actionable insights from complex biological and clinical data to accelerate drug development. Overseeing data science operations, the President, Certara Data Sciences ensures the delivery of cutting-edge solutions that inform critical decision-making for clients. This leadership position involves leveraging AI and machine learning to solve challenging problems in drug discovery and patient outcomes. By driving innovation in data analytics, Martin Snyder directly enhances Certara's ability to provide predictive and prescriptive insights. Ultimately, Snyder empowers clients with data-driven strategies to bring therapies to market faster.
    Martin Snyder

    Paul Gallagher - President & Founder

    Paul Gallagher, the President & Founder at Certara, provides foundational leadership and strategic vision for the company. Gallagher established Certara with a commitment to advancing drug development through innovative services and software. Guiding the company's long-term direction, the President & Founder ensures adherence to the core mission of accelerating therapeutic access. This pivotal role involves fostering key relationships and championing the company's pioneering spirit. By drawing on deep industry knowledge, Paul Gallagher directly influences Certara's strategic growth and market impact. Ultimately, Gallagher continues to shape Certara's legacy as a transformative force in the life sciences sector.

    Adrian McKemey - President, Certara Drug Development Solutions

    Adrian McKemey, the President of Certara Drug Development Solutions at Certara, leads the comprehensive suite of services supporting the entire drug development pipeline. McKemey oversees the integration of scientific expertise and technological platforms to optimize client projects from discovery through regulatory submission. Directing drug development operations, the President, Certara Drug Development Solutions ensures the highest standards of scientific rigor and project execution across global teams. This executive function involves managing complex project portfolios and fostering collaborative client partnerships. By enhancing service delivery and operational efficiency, Adrian McKemey directly contributes to Certara's reputation for excellence and client success. Ultimately, McKemey facilitates the efficient progression of novel therapies to patients.
    Adrian McKemey

    Chris Bouton - Chief Technology Officer

    Chris Bouton, the Chief Technology Officer at Certara, architects the company's technological infrastructure and innovation roadmap. Bouton drives the development and implementation of advanced software solutions that enhance drug discovery and development processes. Overseeing all technology functions, the Chief Technology Officer ensures robust, scalable, and secure platforms for clients globally. This leadership position involves evaluating emerging technologies and integrating them to maintain Certara's competitive edge. By leading digital transformation initiatives, Chris Bouton directly impacts the efficiency and effectiveness of Certara's service offerings. Ultimately, Bouton champions technological advancements that accelerate therapeutic breakthroughs.
    Chris Bouton

    Sheila Rocchio - Chief Marketing Officer

    Sheila Rocchio, the Chief Marketing Officer at Certara, shapes the company's brand strategy and market positioning. Rocchio leads initiatives to communicate Certara's value proposition to the pharmaceutical and biotechnology industries worldwide. Driving market engagement, the Chief Marketing Officer ensures consistent messaging and brand awareness across all communication channels. This executive function involves understanding market dynamics and client needs to inform product development and service offerings. By developing targeted marketing campaigns, Sheila Rocchio directly enhances Certara's market reach and client acquisition efforts. Ultimately, Rocchio strengthens Certara's reputation as a trusted partner in drug development.
    Sheila Rocchio

    Rona Anhalt - Chief Human Resources Officer

    Rona Anhalt, the Chief Human Resources Officer at Certara, leads the company's talent management and organizational development strategies. Anhalt oversees all human resources functions, ensuring Certara attracts, develops, and retains a high-performing global workforce. Championing employee engagement, the Chief Human Resources Officer cultivates a positive and productive work environment that supports Certara's mission. This strategic role involves designing HR policies and programs that align with business objectives and foster a culture of collaboration and innovation. By managing talent acquisition and development, Rona Anhalt directly contributes to Certara's operational capacity and long-term success. Ultimately, Anhalt ensures Certara has the skilled personnel necessary to achieve its ambitious goals.
    Rona Anhalt

    John Gallagher - Interim Chief Development Officer

    John Gallagher, the Interim Chief Development Officer at Certara, provides critical leadership during a transitional phase for the company's development functions. Gallagher oversees key development initiatives, ensuring continuity and progress in advancing Certara's service offerings. Managing development projects, the Interim Chief Development Officer maintains momentum and strategic focus on critical programs. This temporary leadership role involves assessing current development strategies and identifying areas for immediate improvement. By ensuring operational stability, John Gallagher directly supports Certara's ongoing commitment to innovation and client service. Ultimately, Gallagher facilitates a smooth transition and upholds the company's development objectives.

    Cynthia Collins - Member of the Board

    Cynthia Collins, a Member of the Board at Certara, provides strategic oversight and governance. Collins contributes extensive industry experience to guide Certara's long-term vision and corporate direction. Serving on the board, the Member of the Board ensures accountability and promotes sustainable growth. This governance role involves advising executive leadership on critical business decisions and market opportunities. By offering seasoned perspectives, Cynthia Collins directly influences Certara's strategic planning and risk management frameworks. Ultimately, Collins supports the board's fiduciary duty to stakeholders and the company's mission.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Certara Top Executives and Leadership Team

    Who leads Certara?
    Certara is led by Jon Resnick (Chief Executive Officer), along with executives such as Kelly Brooks (Chief Financial Officer) and Martin Snyder (President, Certara Data Sciences).
    Who is part of Certara’s executive team?
    The executive team of Certara includes leaders such as Jon Resnick (Chief Executive Officer), Kelly Brooks (Chief Financial Officer), Martin Snyder (President, Certara Data Sciences) and other senior executives.
    How many executives does Certara have?
    Certara has 10 executives leading key business areas.
    What roles are included in Certara’s leadership team?
    The leadership team of Certara includes roles such as Chief Executive Officer, Chief Financial Officer, President, Certara Data Sciences, President & Founder, President, Certara Drug Development Solutions.